港股异动 | 呷哺呷哺(0520.HK)涨逾5% 投行看高公司股价至18.2港元
格隆汇11月10日丨呷哺呷哺(0520.HK)股价继续走强,盘中最高见15.88港元再度刷新自2018年8月份以来新高,现报15.74港元,涨幅5.5%,最新总市值170.3亿港元;该股年内已累计涨逾55%。花旗研报指,公司餐厅在十一黄金周期间的同店销售跌幅收窄至低单位数,旗下品牌餐厅“凑凑”的同店销售更由9月的下跌低单位数,转至在10月底录得增长。将公司目标价由13.1港元升至18.2港元,评级维持“买入”,并预期集团在明年的同店销售可恢复至去年水平。另外由于新餐厅额外的销售贡献,估计集团明年的销售可较去年水平增长45%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.